LRRC15 and neoplasm: The mechanism of tumor invasion and immune resistance involving COL6A3, COL1A1, COL1A2, LRRC15, IDO1, IL-6 and PTGS2 need to be further researched aiming to improve prognosis of aggressive glioblastoma.